These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25236993)

  • 1. The Nocturia Impact Diary: a self-reported impact measure to complement the voiding diary.
    Holm-Larsen T; Andersson F; van der Meulen E; Yankov V; Rosen RC; Nørgaard JP
    Value Health; 2014 Sep; 17(6):696-706. PubMed ID: 25236993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new patient-reported outcome (PRO) measure on the Impact of Nighttime Urination (INTU) in patients with nocturia-Psychometric validation.
    Bennett JB; Gillard KK; Banderas B; Abrams S; Cheng L; Fein S
    Neurourol Urodyn; 2018 Jun; 37(5):1678-1685. PubMed ID: 29574972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK; Dmochowski RR; Reddy J; van der Meulen EA
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric validation and interpretation of the Nocturia Impact Diary in a clinical trial setting.
    Hudgens S; Howerter A; Polek E; Andersson FL
    Qual Life Res; 2022 Jun; 31(6):1837-1848. PubMed ID: 34932192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP; Herschorn S; Albei CD; van der Meulen EA
    J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the Nocturia Sleep Quality Scale: a patient-reported outcome measure of sleep impact related to nocturia.
    Romano CD; Lewis S; Barrett A; Andersson FL; Williams V; Ancoli-Israel S; Roth T
    Sleep Med; 2019 Jul; 59():101-106. PubMed ID: 31072693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the Impact of Nighttime Urination (INTU) questionnaire to assess the impact of nocturia on health and functioning.
    Abrams S; Martin S; Gillard KK; Cheng L; Fein S
    Neurourol Urodyn; 2018 Jun; 37(5):1686-1692. PubMed ID: 29566269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Item-level psychometric properties for a new patient-reported psoriasis symptom diary.
    Strober BE; Nyirady J; Mallya UG; Guettner A; Papavassilis C; Gottlieb AB; Elewski BE; Turner-Bowker DM; Shields AL; Gwaltney CJ; Lebwohl M
    Value Health; 2013; 16(6):1014-22. PubMed ID: 24041351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population.
    Bing MH; Moller LA; Jennum P; Mortensen S; Lose G
    Eur Urol; 2006 Apr; 49(4):710-9. PubMed ID: 16442700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demystifying nocturia: identifying the cause and tailoring the treatment.
    Laureanno P; Ellsworth P
    Urol Nurs; 2010; 30(5):276-86; quiz 287. PubMed ID: 21067093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
    Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP
    BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Content validation of symptom-specific nocturia quality-of-life instrument developed in men: issues expressed by women, as well as men.
    Mock LL; Parmelee PA; Kutner N; Scott J; Johnson TM
    Urology; 2008 Oct; 72(4):736-42. PubMed ID: 18684494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish (Spain) validation of a specific symptomatic questionnaire for male patients with nocturia.
    Vicente E; Barrio M; Gual J; Fadil Y; Capdevila M; Muñoz J; Garcia D; Hannaoui N; Prats J
    Neurourol Urodyn; 2016 Sep; 35(7):847-50. PubMed ID: 26179109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP; Zinner NR; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological studies of orofacial aesthetics, orofacial function and oral health-related quality of life.
    Larsson P
    Swed Dent J Suppl; 2010; (204):11-98. PubMed ID: 20623943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturia: an Austrian study on the multifactorial etiology of this symptom.
    Klingler HC; Heidler H; Madersbacher H; Primus G
    Neurourol Urodyn; 2009; 28(5):427-31. PubMed ID: 19229953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.
    Huxley P; Evans S; Madge S; Webber M; Burchardt T; McDaid D; Knapp M
    Health Technol Assess; 2012; 16(1):iii-vii, ix-xii, -1-241. PubMed ID: 22260923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire.
    Sakane Y; Yamaguchi M; Yokoi N; Uchino M; Dogru M; Oishi T; Ohashi Y; Ohashi Y
    JAMA Ophthalmol; 2013 Oct; 131(10):1331-8. PubMed ID: 23949096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
    Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P
    Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument.
    Lebwohl M; Swensen AR; Nyirady J; Kim E; Gwaltney CJ; Strober BE
    Int J Dermatol; 2014 Jun; 53(6):714-22. PubMed ID: 23557000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.